+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gel Column Agglutination Test system Market by Test Type, End User, Product Type, Application, Sample Type, Blood Group System - Global Forecast to 2030- Product Image
Gel Column Agglutination Test system Market by Test Type, End User, Product Type, Application, Sample Type, Blood Group System - Global Forecast to 2030- Product Image
Sale

Gel Column Agglutination Test system Market by Test Type, End User, Product Type, Application, Sample Type, Blood Group System - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016417
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gel Column Agglutination Test system Market grew from USD 3.50 billion in 2024 to USD 3.73 billion in 2025. It is expected to continue growing at a CAGR of 6.56%, reaching USD 5.12 billion by 2030.

Navigating the Evolution of Gel Column Agglutination Testing

The gel column agglutination test system has transformed immunohematology by offering enhanced reliability, automation, and throughput compared to traditional tube-based assays. In this introduction, we present an overview of the core principles underpinning gel column agglutination technology, tracing its evolution from manual methods to sophisticated platforms that integrate computerized analysis and standardized reagents. Our analysis underscores the critical importance of accurate antibody screening, precise crossmatching procedures, and detailed antigen phenotyping in ensuring transfusion safety and diagnostic accuracy.

Today’s laboratories demand solutions that minimize human error while maximizing workflow efficiency. Gel columns rely on dextran acrylamide matrices and specific reagents to capture agglutinated cells, offering clear visual endpoints and reducing the risk of false positives or negatives. This technology’s compatibility with both automated and semi-automated systems streamlines sample processing, allowing high-volume blood banks, diagnostic laboratories, and hospitals to deliver rapid, reproducible results. As we embark on this executive summary, readers will gain a comprehensive understanding of the market’s drivers, regulatory influences, and transformative trends shaping the future of gel column agglutination testing.

Emerging Trends Shaping Gel Column Agglutination Technology

The landscape of gel column agglutination testing is undergoing transformative shifts driven by technological innovation and evolving clinical needs. Recent advances in microfluidics and digital image analysis have introduced compact, high-throughput instruments capable of interpreting complex serological patterns with unprecedented precision. Meanwhile, reagent card developers are formulating novel antibody panels that reduce turnaround times and broaden the scope of detectable antigens, enabling rapid responses during mass screening or emergency transfusion scenarios.

Simultaneously, regulatory bodies are advocating for stricter validation protocols and encouraging harmonization of testing standards across regions. This regulatory momentum is compelling manufacturers to invest in product quality, traceability, and user training programs. At the same time, collaborative initiatives between diagnostic firms and academic institutions are accelerating the development of next-generation reagents targeting rare blood group systems. Together, these trends are reshaping the competitive dynamics, incentivizing companies to differentiate through integrated software solutions, remote monitoring capabilities, and cloud-based data management platforms that support real-time decision-making in clinical environments.

Assessing the Impact of 2025 Tariffs on the United States Market

In 2025, the introduction of new United States tariffs has created notable headwinds for stakeholders in the gel column agglutination test systems market. These duties have increased the landed cost of critical reagents and imported instrumentation components, prompting laboratories and distributors to reassess procurement strategies. For domestic manufacturers, the tariffs have presented an opportunity to reinforce local supply chains and accelerate in-country production of gel columns, reagent cards, and ancillary consumables. This realignment has not only mitigated some cost pressures but also stimulated collaborations between instrument producers and reagent suppliers to develop vertically integrated solutions that bypass import constraints.

Despite these challenges, some end users have leveraged the tariff-induced cost environment to negotiate volume-based agreements, securing deeper discounts and service-level commitments. Scientific research institutes, in particular, have explored alternative sourcing channels and localized reagent formulation, while blood banks have adopted predictive inventory management tools to optimize stock levels and reduce wastage. As the market adapts, stakeholders are increasingly focused on balancing short-term cost containment with long-term investments in automated systems and semi-automated platforms, ensuring resilience against supply chain disruptions and regulatory fluctuations.

Unveiling Key Market Segmentation Dynamics

The gel column agglutination testing market encompasses a diverse array of testing modalities, end-user segments, product categories, application areas, sample types, and blood group systems. Test type variations span antibody screening protocols administered through three-cell and two-cell panels, crossmatching workflows that include both electronic and manual approaches, grouping procedures leveraging forward and reverse methodologies, and advanced identification assays such as extended phenotyping and panel identification. End users range from private and public blood banks to diagnostic laboratories that operate within hospital and reference settings, as well as hospitals offering secondary and tertiary care services and research institutes engaged in academic and pharmaceutical investigations.

On the product side, consumables comprise gel columns and reagent cards, while instruments include both fully automated and semi-automated systems designed for varying throughput requirements. Applications extend across immunohematology-driven blood transfusion processes, including pretransfusion testing, as well as disease diagnostics targeting autoimmune disorders and infectious disease markers, and research activities that span academic studies and clinical trials. Sample types encompass plasma derivatives such as cryoprecipitate and fresh frozen plasma, red cell preparations including packed and washed red cells, and whole blood specimens preserved with citrate or EDTA. Furthermore, testing protocols address multiple blood group systems, from the ubiquitous ABO classification subtypes A, AB, B, and O, to specialized Kell antigens K1 and K2, and Rh antigens including C, c, D, E, and e. An in-depth understanding of these segmentation layers reveals distinct growth drivers, competitive pressures, and technological requirements across the market spectrum.

Regional Variations Driving Market Growth

Regional dynamics in the gel column agglutination market are shaped by diverse healthcare infrastructures, funding models, and disease prevalence patterns. In the Americas, established blood banking networks and robust reimbursement frameworks have fostered widespread adoption of automated systems, while emerging research initiatives in Latin America are driving demand for cost-effective reagent cards. Meanwhile, Europe, Middle East & Africa present a heterogeneous landscape where regulatory convergence in the European Union supports standardized testing protocols, yet resource constraints in certain African markets create opportunities for portable semi-automated platforms.

In the Asia-Pacific region, rapid expansion of private healthcare facilities and increased public investment in diagnostic capabilities have spurred growth in both consumable and instrument segments. China and India are witnessing significant capital expenditure in tertiary care hospitals, with blood banks and diagnostic laboratories prioritizing streamlined workflows and enhanced safety profiles. Across all regions, the interplay between local manufacturing capacities, import regulations, and clinical practice guidelines determines the pace of market penetration for next-generation gel column agglutination solutions.

Competitive Landscape and Leading Innovators

Leading players in the gel column agglutination test system arena are leveraging strategic partnerships, product innovation, and geographic expansion to maintain competitive advantage. Established diagnostics firms have introduced modular platforms that offer seamless integration with laboratory information systems, enabling remote monitoring and predictive maintenance. Some companies have diversified their portfolios by acquiring niche reagent manufacturers to bolster their offering of specialized antibody screening panels.

At the same time, emerging technology providers are challenging incumbents with compact, user-friendly instruments tailored for low-volume laboratories, emphasizing cost efficiency without compromising analytical performance. Collaborative ventures between automation specialists and reagent developers are resulting in turn-key solutions that simplify training requirements and accelerate implementation. Furthermore, several market leaders have enhanced their global reach through distribution alliances in key growth regions, ensuring rapid aftermarket service and localized technical support for both consumables and instrumentation.

Strategic Imperatives for Industry Leaders

To capitalize on the transformative potential of gel column agglutination systems, industry leaders should prioritize collaborative ecosystems that encompass reagent suppliers, instrument manufacturers, and software developers. Investing in modular automation platforms will enable rapid scalability across different testing volumes while preserving flexibility to adapt to evolving clinical guidelines. Enhancing reagent stability and shelf life through advanced formulation techniques can reduce logistical burdens and expand access in remote or resource-limited settings.

Developing training programs and digital support tools will foster user proficiency, driving adoption and reducing operator-related variability. Strategic engagement with regulatory authorities to shape harmonized validation standards can accelerate time to market for novel solutions. In parallel, companies should explore strategic acquisitions or partnerships with emerging regional players to establish localized manufacturing hubs and optimize supply chain resilience. Finally, integrating cloud-based analytics and artificial intelligence modules will unlock deeper insights from serological data, enabling predictive diagnostics and personalized transfusion management strategies.

Robust Multi-Methodological Research Approach

Our research methodology combined a rigorous review of primary and secondary sources to ensure comprehensive coverage of the gel column agglutination test systems market. Primary research included in-depth interviews with key opinion leaders, laboratory directors, and procurement specialists, supplemented by site visits to blood banks and diagnostic laboratories across major regions. Secondary sources encompassed peer-reviewed journals, regulatory filings, company financial reports, and industry white papers. Data triangulation techniques were applied to validate findings and reconcile discrepancies between different information streams.

Quantitative analyses were underpinned by detailed segmentation models and comparative benchmarking of product features, pricing structures, and service offerings. Qualitative insights were drawn from thematic evaluations of innovation pipelines, strategic partnerships, and regulatory developments. This multi-methodological approach ensured that the report delivers actionable intelligence grounded in both market realities and forward-looking perspectives.

Synthesis of Insights and Future Outlook

The gel column agglutination test systems market stands at a pivotal juncture, with technological innovation reshaping testing paradigms and regulatory trends influencing global adoption. Manufacturers and end users alike must navigate evolving tariffs, dynamic segmentation landscapes, and region-specific challenges to harness the full potential of this platform. By aligning strategic priorities with emerging trends-such as automated workflows, digital analytics, and advanced reagent formulations-stakeholders can drive efficiency, accuracy, and patient safety.

Looking ahead, the integration of artificial intelligence, point-of-care adaptations, and sustainable reagent practices will define the next wave of growth. Industry collaboration, regulatory harmonization, and targeted investment in emerging markets will further catalyze adoption, ensuring that gel column agglutination technology remains at the forefront of immunohematology testing solutions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Antibody Screening
      • Three-Cell Panel
      • Two-Cell Panel
    • Crossmatch
      • Electronic Crossmatch
      • Manual Crossmatch
    • Grouping
      • Forward Grouping
      • Reverse Grouping
    • Identification
      • Extended Phenotyping
      • Panel Identification
  • End User
    • Blood Banks
      • Private Blood Banks
      • Public Blood Banks
    • Diagnostic Laboratories
      • Hospital Laboratories
      • Reference Laboratories
    • Hospitals
      • Secondary Care
      • Tertiary Care
    • Research Institutes
      • Academic Institutes
      • Pharmaceutical Companies
  • Product Type
    • Consumables
      • Gel Columns
      • Reagent Cards
    • Instruments
      • Automated Systems
      • Semi-Automated Systems
  • Application
    • Blood Transfusion
      • Immunohematology
      • Pretransfusion Testing
    • Disease Diagnostics
      • Autoimmune Disorders
      • Infectious Disease Markers
    • Research
      • Academic Research
      • Clinical Trials
  • Sample Type
    • Plasma
      • Cryoprecipitate
      • Fresh Frozen Plasma
    • Red Cells
      • Packed Red Cells
      • Washed Red Cells
    • Whole Blood
      • Citrated Blood
      • EDTA Blood
  • Blood Group System
    • ABO
      • A
      • AB
      • B
      • O
    • Duffy
    • Kell
      • K1
      • K2
    • Kidd
    • MNS
    • Rh
      • C
      • c
      • D
      • E
      • e
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ortho Clinical Diagnostics Holdings plc
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Immucor, Inc.
  • Diagast
  • Abacus Diagnostica Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gel Column Agglutination Test system Market, by Test Type
8.1. Introduction
8.2. Antibody Screening
8.2.1. Three-Cell Panel
8.2.2. Two-Cell Panel
8.3. Crossmatch
8.3.1. Electronic Crossmatch
8.3.2. Manual Crossmatch
8.4. Grouping
8.4.1. Forward Grouping
8.4.2. Reverse Grouping
8.5. Identification
8.5.1. Extended Phenotyping
8.5.2. Panel Identification
9. Gel Column Agglutination Test system Market, by End User
9.1. Introduction
9.2. Blood Banks
9.2.1. Private Blood Banks
9.2.2. Public Blood Banks
9.3. Diagnostic Laboratories
9.3.1. Hospital Laboratories
9.3.2. Reference Laboratories
9.4. Hospitals
9.4.1. Secondary Care
9.4.2. Tertiary Care
9.5. Research Institutes
9.5.1. Academic Institutes
9.5.2. Pharmaceutical Companies
10. Gel Column Agglutination Test system Market, by Product Type
10.1. Introduction
10.2. Consumables
10.2.1. Gel Columns
10.2.2. Reagent Cards
10.3. Instruments
10.3.1. Automated Systems
10.3.2. Semi-Automated Systems
11. Gel Column Agglutination Test system Market, by Application
11.1. Introduction
11.2. Blood Transfusion
11.2.1. Immunohematology
11.2.2. Pretransfusion Testing
11.3. Disease Diagnostics
11.3.1. Autoimmune Disorders
11.3.2. Infectious Disease Markers
11.4. Research
11.4.1. Academic Research
11.4.2. Clinical Trials
12. Gel Column Agglutination Test system Market, by Sample Type
12.1. Introduction
12.2. Plasma
12.2.1. Cryoprecipitate
12.2.2. Fresh Frozen Plasma
12.3. Red Cells
12.3.1. Packed Red Cells
12.3.2. Washed Red Cells
12.4. Whole Blood
12.4.1. Citrated Blood
12.4.2. EDTA Blood
13. Gel Column Agglutination Test system Market, by Blood Group System
13.1. Introduction
13.2. ABO
13.2.1. A
13.2.2. AB
13.2.3. B
13.2.4. O
13.3. Duffy
13.4. Kell
13.4.1. K1
13.4.2. K2
13.5. Kidd
13.6. MNS
13.7. Rh
13.7.1. C
13.7.2. c
13.7.3. D
13.7.4. E
13.7.5. e
14. Americas Gel Column Agglutination Test system Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Gel Column Agglutination Test system Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Gel Column Agglutination Test system Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Ortho Clinical Diagnostics Holdings plc
17.3.2. Bio-Rad Laboratories, Inc.
17.3.3. Grifols, S.A.
17.3.4. Thermo Fisher Scientific Inc.
17.3.5. Danaher Corporation
17.3.6. Abbott Laboratories
17.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.3.8. Immucor, Inc.
17.3.9. Diagast
17.3.10. Abacus Diagnostica Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY THREE-CELL PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TWO-CELL PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ELECTRONIC CROSSMATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MANUAL CROSSMATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FORWARD GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REVERSE GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EXTENDED PHENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PANEL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GEL COLUMNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY REAGENT CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PACKED RED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WASHED RED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CITRATED BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY EDTA BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY A, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY AB, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY B, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY O, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DUFFY, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY K1, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY K2, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KIDD, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY MNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY C, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY C, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY D, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY E, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY E, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 148. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 149. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 150. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 151. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 152. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 153. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 155. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 160. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 163. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 164. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 165. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 166. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 167. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 168. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 169. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 170. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 171. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 172. CANADA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 173. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 175. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 176. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 177. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 178. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 188. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 189. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 192. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 194. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 195. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 196. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 197. MEXICO GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 215. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 217. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 218. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 219. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 220. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 221. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 222. BRAZIL GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 225. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 226. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 227. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 228. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 230. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 231. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 233. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 235. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 238. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 240. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 241. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 242. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 243. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 244. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 245. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 246. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 247. ARGENTINA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RED CELLS, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY WHOLE BLOOD, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD GROUP SYSTEM, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ABO, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY KELL, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RH, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CROSSMATCH, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY GROUPING, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM GEL COLUMN AGGLUTINATION TEST SYSTEM MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gel Column Agglutination Test system market report include:
  • Ortho Clinical Diagnostics Holdings plc
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Immucor, Inc.
  • Diagast
  • Abacus Diagnostica Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.12 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Latex Agglutination Test Kits - Global Strategic Business Report - Product Image

Latex Agglutination Test Kits - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From
Latex Agglutination Test Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Latex Agglutination Test Kits Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Latex Agglutination Test Kits Market Report 2025 - Product Image

Latex Agglutination Test Kits Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chromatography Accessories & Consumables Market by Product Type, Technique, Application, End User - Global Forecast to 2030 - Product Image

Chromatography Accessories & Consumables Market by Product Type, Technique, Application, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Gel Permeation Chromatography Systems Market by Technology, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Gel Permeation Chromatography Systems Market by Technology, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From

About the Gel Column Agglutination Test Market

The Gel Column Agglutination Test (GCAT) is a type of coagulation and hemostasis testing used to detect the presence of antigens in a sample. It is a rapid, automated test that uses a gel column to separate antigens from the sample. The test is used to detect a variety of antigens, including those associated with autoimmune diseases, infections, and other conditions. GCAT is used in clinical laboratories to diagnose and monitor a variety of conditions, including autoimmune diseases, infections, and other conditions. GCAT is a cost-effective and reliable method of testing for antigens. It is a rapid test that can be completed in a short amount of time, making it ideal for use in clinical settings. Additionally, the test is highly sensitive and specific, making it a reliable method of testing for antigens. The GCAT market is a growing market, with a number of companies offering products and services related to the test. Companies such as Abbott, Siemens, Roche, and Beckman Coulter are some of the major players in the market. Other companies such as Bio-Rad, Ortho Clinical Diagnostics, and Sysmex are also offering products and services related to the GCAT test. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.